161 related articles for article (PubMed ID: 32736779)
1. Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer.
Gerotziafas GT; Mahé I; Lefkou E; AboElnazar E; Abdel-Razeq H; Taher A; Antic D; Elalamy I; Syrigos K; Van Dreden P
Thromb Res; 2020 Jul; 191 Suppl 1():S50-S57. PubMed ID: 32736779
[TBL] [Abstract][Full Text] [Related]
2. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.
Gerotziafas GT; Taher A; Abdel-Razeq H; AboElnazar E; Spyropoulos AC; El Shemmari S; Larsen AK; Elalamy I;
Oncologist; 2017 Oct; 22(10):1222-1231. PubMed ID: 28550032
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
[TBL] [Abstract][Full Text] [Related]
4. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
[TBL] [Abstract][Full Text] [Related]
5. Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer.
Xiong W; Zhao Y; Du H; Wang Y; Xu M; Guo X
Thromb J; 2021 Dec; 19(1):95. PubMed ID: 34863189
[TBL] [Abstract][Full Text] [Related]
6. COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
Abdel-Razeq H; Sharaf B; Al-Jaghbeer MJ; Abu-Fares H; Bater R; Shaer MA; Abu-Jaish H; Laban DA; Salamah O; Tamimi F; Ashouri K; Salameh T; Zughul R; Alhalaseh Y
J Thromb Thrombolysis; 2023 Oct; 56(3):447-453. PubMed ID: 37430158
[TBL] [Abstract][Full Text] [Related]
7. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
[No Abstract] [Full Text] [Related]
8. Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.
Verzeroli C; Giaccherini C; Russo L; Bolognini S; Gamba S; Tartari CJ; Schieppati F; Ticozzi C; Vignoli A; Masci G; Sarmiento R; Spinelli D; Malighetti P; Tondini C; Petrelli F; Giuliani F; D'Alessio A; Gasparini G; Minelli M; De Braud F; Santoro A; Labianca R; Marchetti M; Falanga A;
J Thromb Haemost; 2023 Jul; 21(7):1869-1881. PubMed ID: 37054917
[TBL] [Abstract][Full Text] [Related]
9. Comparison among three predictive models for cancer-associated thromboembolism in a hispanic population.
Ramos-Esquivel A; Marenco-Flores A; Hernández-Romero G; Céspedes-Calvo A; Mora-Hidalgo R
J Thromb Thrombolysis; 2023 Oct; 56(3):433-438. PubMed ID: 37407771
[TBL] [Abstract][Full Text] [Related]
10. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Newman P; Mortazavi R
Thromb Res; 2024 Feb; 234():120-133. PubMed ID: 38215613
[TBL] [Abstract][Full Text] [Related]
11. Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients.
Di Nisio M; van Es N; Rotunno L; Anzoletti N; Falcone L; De Tursi M; Natoli C; Tinari N; Cavallo I; Valeriani E; Candeloro M; Guglielmi MD; Rutjes AWS; Porreca E
J Thromb Thrombolysis; 2019 Jul; 48(1):125-133. PubMed ID: 30919253
[TBL] [Abstract][Full Text] [Related]
12. Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study.
Syrigos K; Grapsa D; Sangare R; Evmorfiadis I; Larsen AK; Van Dreden P; Boura P; Charpidou A; Kotteas E; Sergentanis TN; Elalamy I; Falanga A; Gerotziafas GT
Oncologist; 2018 Nov; 23(11):1372-1381. PubMed ID: 30104289
[TBL] [Abstract][Full Text] [Related]
13. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.
Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M
Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201
[TBL] [Abstract][Full Text] [Related]
14. Assessing the risk of venous thromboembolism in patients with haematological cancers using three prediction models.
El-Sayed HA; Othman M; Azzam H; Bucciol R; Ebrahim MA; El-Agdar MAMA; Tera Y; Sakr DH; Ghoneim HR; Selim TE
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17771-17780. PubMed ID: 37935936
[TBL] [Abstract][Full Text] [Related]
15. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
[TBL] [Abstract][Full Text] [Related]
16. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.
Pabinger I; van Es N; Heinze G; Posch F; Riedl J; Reitter EM; Di Nisio M; Cesarman-Maus G; Kraaijpoel N; Zielinski CC; Büller HR; Ay C
Lancet Haematol; 2018 Jul; 5(7):e289-e298. PubMed ID: 29885940
[TBL] [Abstract][Full Text] [Related]
17. A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.
Gomez-Rosas P; Giaccherini C; Russo L; Verzeroli C; Gamba S; Tartari CJ; Bolognini S; Ticozzi C; Schieppati F; Barcella L; Sarmiento R; Masci G; Tondini C; Petrelli F; Giuliani F; D'Alessio A; Minelli M; De Braud F; Santoro A; Labianca R; Gasparini G; Marchetti M; Falanga A; On Behalf Of The Hypercan Investigators
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760562
[TBL] [Abstract][Full Text] [Related]
18. Estimating Venous Thromboembolism Risk in Metastatic Colorectal Cancer Inpatients: Validation of Existing Risk Scores and Development of New Risk Scores.
Qin L; Liang Z; Xie J; Li X
Clin Appl Thromb Hemost; 2023; 29():10760296231196859. PubMed ID: 37691565
[TBL] [Abstract][Full Text] [Related]
19. The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma.
Abdel-Razeq H; Ma'koseh M; Mansour A; Bater R; Amarin R; Abufara A; Halahleh K; Manassra M; Alrwashdeh M; Almomani M; Zmaily M
Clin Appl Thromb Hemost; 2021; 27():10760296211045908. PubMed ID: 34590497
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients.
Schorling RM; Pfrepper C; Golombek T; Cella CA; Muñoz-Unceta N; Siegemund R; Engel C; Petros S; Lordick F; Knödler M
Oncol Res Treat; 2020; 43(9):414-427. PubMed ID: 32580190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
